Financial Statements 2Q 2020 of SCPI
Tuesday, August 11, 2020       15:17 WIB

PT Merck Sharp Dohme Pharma Tbk () membukukan laba bersih pada Quarter 2 2020 sebesar 127,6 miliar. Naik bila di bandingkan dengan periode yang sama di tahun 2019 sebesar 72,6 miliar. Dengan demikian, laba bersih per saham setara dengan Rp 35.45 per lembar.
Berikut Laporan keuangan Quarter 2 2020 :
AccountQuarter 2 2020
Last Price29000
Share Out3,6 M
Market Cap.104,4 B
Balance Sheet
Cash27,9 B
Total Asset1.762,7 B
S.T Debt565,2 B
L.T Debt452,9 B
Total Equity744,6 B
Income Statement
Revenue1.329,4 B
Gross Profit179,8 B
Operating Profit160,5 B
Net. Profit127,6 B
EBITDA175,0 B
Interest Exp.13,4 B
Ratio
Deviden0,00
EPS35,45
PER818,05x
BVPS 206.837,02
PBV0,14x
ROA7,24%
ROE17,14%
EV/EBITDA6,25
Debt/Equity1,37
Debt/TotalCap0,58
Debt/EBITDA5,82
EBITDA/IntExp.13,03

Sumber : IPS RESEARCH

berita terbaru
Saturday, May 04, 2024 - 18:47 WIB
GOTO Berencana Private Placement dan Buyback Saham
Saturday, May 04, 2024 - 18:37 WIB
Financial Statements 1Q 2024 of KARW
Saturday, May 04, 2024 - 18:32 WIB
Financial Statements 1Q 2024 of GDST
Saturday, May 04, 2024 - 18:27 WIB
Financial Statements 1Q 2024 of IKPM
Saturday, May 04, 2024 - 18:22 WIB
Financial Statements 1Q 2024 of YPAS
Saturday, May 04, 2024 - 18:19 WIB
Financial Statements 1Q 2024 of TYRE
Saturday, May 04, 2024 - 18:16 WIB
Financial Statements 1Q 2024 of IGAR